About Hudson RCI
Hudson RCI is a Healthcare company based in Temecula (United States) founded in 1945, and was acquired by Teleflex Medical in May 2004. Disposable respiratory and anesthesia products are supplied for patient care. Its focus areas include Life Sciences, Pulmonology, Medical Devices and Therapeutic Devices. Its competitors include Third Pole Therapeutics, Vyaire and Ventec Life Systems; 3 of its 3 listed competitors have raised funding.
Company details
Hudson provides disposable respiratory and anesthesia products for the treatment of chronic respiratory disease. They offer their customers a full range of products for oxygen delivery, humidification, airway management, anaesthesia and ventilatory support. Products include the Humid-Vent heat and moisture exchangers, CONCHATHERM heated humidifiers or AQUAPAK prefilled humidifiers and nebulizers . They got acquired by Teleflex in May 2004.
- Headquarters Temecula, United States
- Stage Acquired
- SectorsHealthcare
- Website hudsonrci.com
- Acquired by Teleflex Medical (May 2004)
- InvestorsTeleflex Medical
& 1 more
- Acquired byTeleflex Medical
(May 2004)
Funding Insights of Hudson RCI
- Total Rounds 2
- Investors Count 1
All 2 funding rounds of Hudson RCI with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2007 | Private Equity Round | – | – | ||
| Feb 1998 | Private Equity Round | – | – |
2 investors in total: 2 institutional.
Investors in Hudson RCI
Hudson RCI has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Teleflex Medical and Freeman Spogli.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
North American private equity investments are managed by Freeman Spogli. | 1983 | freemanspogli.com | Los Angeles, United States | |
Provider of medical devices for emergency medicine and various health conditions | 1943 | teleflex.com | Wayne, United States |
Investor details for Hudson RCI
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Hudson RCI
703 people are tracked at Hudson RCI (183 in leadership, 520 in team).
| Name | Role | Group |
|---|---|---|
Berthtranda Marie Denby | General Manager, Vascular Access & Trauma And Emergency Medicine | Leadership |
Damian Scherrer | VP Finance & Services - Business Unit Vascular Intervention Bei Teleflex | Leadership |
Bert Lane | VP, Global Logistics & Distribution | Leadership |
Daniel V. Logue | Corporate VP, General Counsel and Secretary | Leadership |
Matthew James | President, EMEA & Global Urology | Leadership |
Lisa Kudlacz | President & General Manager, Vascular | Leadership |
Sharon Haughney | Director, Talent Acquisition - The Americas | Leadership |
Nishith Desai | Vice President Of Global Regulatory Affairs | Leadership |
Praneet Mehrotra | President, APAC | Leadership |
Lawrence Keusch | VP, Investor Relations and Strategy Development | Leadership |
Raphael Ong | APAC Director, Strategy, Marketing & Commercial Excellence | Leadership |
Marisa Walsh | Senior Director Regulatory Affairs | Leadership |
Matthew Wiggins | Senior Director Of Marketing, Global Urology | Leadership |
Piu Maji | Head Human Resources South Asia | Leadership |
Howard Cyr | Corporate VP & Chief Compliance Officer | Leadership |
Dori Garcia Diaz | Director, Global Performance Management & EMEA Talent Development | Leadership |
Frances Mitchell Valantič | Director, Innovation Strategy And Insights, Global Commercial | Leadership |
Sadaf Kohestani-Panesar | EMEA Talent Acquisition Partner | Leadership |
Arnaud Felber | Head Of R&d Partnerships & Drug Coating Development | Leadership |
Basil A. Fanti | Sr Director Operations | Leadership |
683 more people are available in the full profile.
Complete people profiles for Hudson RCI
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Hudson RCI
4 dated milestones of Hudson RCI across 62 years, from founding to its latest funding, stage changes and deals.
- Founded Hudson RCI is founded.
- Funding First funding round.
- Exit Acquired by Teleflex Medical.
- Funding Latest funding round, Private Equity Round,.
Competitors of Hudson RCI
Hudson RCI has 3 listed competitors in our database, 3 of them funded. They include Third Pole Therapeutics, Vyaire and Ventec Life Systems.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pole3.com | 2014 | Boston, United States | $87.6M | Developer of devices for cardiopulmonary therapies | ||
| vyaire.com | 2016 | Illinois, United States | $31.53M | 7 | Respiratory devices for diagnostics, ventilation, and patient monitoring are developed. | |
| venteclife.com | 2013 | Bothell, United States | $60.59M | 103 | Respiratory devices for ICU settings are developed and manufactured. |
Detailed competitors of Hudson RCI
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pulmonology
3 companies that operate in the same segment as Hudson RCI (Pulmonology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of novel protein-based therapeutics using machine learning and biological engineering | 2018 | Somerville, Massachusetts, United States | USD 693 M | 329 | ||
Portable oxygen concentrators are supplied for respiratory therapy needs. | 2001 | Goleta, California, United States | USD 51.65 M | USD 348.67 M | 766 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Hudson RCI
Hudson RCI was founded in 1945 and raised its 1st funding round 53 years after it was founded.
Hudson RCI is headquartered in Temecula, United States. It is registered at Temecula, California, United States.
Hudson provides disposable respiratory and anesthesia products for the treatment of chronic respiratory disease. They offer their customers a full range of products for oxygen delivery, humidification, airway management, anaesthesia and ventilatory support. Products include the Humid-Vent heat and moisture exchangers, CONCHATHERM heated humidifiers or AQUAPAK prefilled humidifiers and nebulizers . They got acquired by Teleflex in May 2004.
Hudson RCI's top competitors include Vyaire, Third Pole Therapeutics and Ventec Life Systems.
Hudson RCI has 2 investors. Key investors include Teleflex Medical, and Freeman Spogli.
Yes. Hudson RCI was acquired by Teleflex Medical in May 2004.